e-learning
resources
ERJ
2006
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The effect of tiotropium on exacerbations and airflow in patients with COPD
Dusser D., Bravo M-L., Iacono P., on behalf the MIS...
Source:
Eur Respir J 2006; 27: 547-555
Journal Issue:
March
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Dusser D., Bravo M-L., Iacono P., on behalf the MIS.... The effect of tiotropium on exacerbations and airflow in patients with COPD. Eur Respir J 2006; 27: 547-555
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease
Source: Eur Respir J 2002; 19: 217-224
Year: 2002
NVA237, a once-daily anticholinergic, demonstrates sustained bronchodilation and is well tolerated in patients with reversible obstructive airways disease
Source: Annual Congress 2006 - Recent advances in the treatment of COPD
Year: 2006
Pharmacodynamic steady state of tiotropium in patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2002; 19: 639-644
Year: 2002
Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium
Source: Eur Respir J 2002; 19: 209-216
Year: 2002
Bronchodilator responsiveness in patients with COPD
Source: Eur Respir J 2008; 31: 742-750
Year: 2008
A trial of beclomethasone/formoterol in COPD using EXACT-PRO to measure exacerbations
Source: Eur Respir J 2013; 41: 12-17
Year: 2013
Exercise and dyspnoea in COPD
Source: Eur Respir Rev 2006; 15: 72-79
Year: 2006
Effect of salmeterol on the ventilatory response to exercise in chronic obstructive pulmonary disease
Source: Eur Respir J 2004; 24: 86-94
Year: 2004
Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD
Source: Eur Respir J 2004; 23: 832-840
Year: 2004
Treatment with corticosteroids and yearly decline of forced expiratory flow (FEV
1
) in patients with severe chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2008 - Respiratory structure and function
Year: 2008
QVA149 improves lung function and reduces exacerbations compared to tiotropium in patients with severe-to-very severe COPD: The SPARK study
Source: Annual Congress 2013 –Asthma and COPD management: novel clinical findings
Year: 2013
Frequency of COPD exacerbations and severity of COPD
Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations
Year: 2013
First dose response to tiotropium in COPD: Impact on dyspnea, lung hyperinflation and distal airways
Source: Annual Congress 2013 –COPD drugs: new findings
Year: 2013
Impacting patient-centred outcomes in COPD: exacerbations and hospitalisations
Source: Eur Respir Rev 2006; 15: 47-51
Year: 2006
The effect of pulmonary rehabilitation toward expiratory airflow limitation in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2011 - Challenges in rehabilitation: some old dilemmas revisited with some solutions?
Year: 2011
Clinical characteristics of patients with clinically-diagnosed COPD exacerbations but without concomitant airflow limitation
Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD
Year: 2015
Tiotropium as essential maintenance therapy in COPD
Source: Eur Respir Rev 2006; 15: 51-57
Year: 2006
Improvement in FEV1 after acute COPD exacerbations are driven more by changes in hyperinflation than changes in proximal airway volume
Source: International Congress 2015 – Clinical physiology: from airways, lung and respiratory muscles to dyspnoea in health and disease
Year: 2015
Clinical effectiveness of nebulized budesonide in the treatment of acute asthma and exacerbations of chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2001; 18: Suppl. 33, 146s
Year: 2001
Interpreting thresholds for a clinically significant change in health status in asthma and COPD
Source: Eur Respir J 2002; 19: 398-404
Year: 2002
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept